<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="78116">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02088554</url>
  </required_header>
  <id_info>
    <org_study_id>PERIGON</org_study_id>
    <nct_id>NCT02088554</nct_id>
  </id_info>
  <brief_title>PERIGON Pivotal Trial</brief_title>
  <acronym>PERIGON</acronym>
  <official_title>Medtronic PERIcardial SurGical AOrtic Valve ReplacemeNt Pivotal Trial A Multi-center, Non-randomized Trial to Determine the Safety and Effectiveness of the Model 400 Aortic Valve Bioprosthesis in Patients With Aortic Valve Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medtronic Cardiovascular</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and effectiveness of the Model 400 aortic valve bioprosthesis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, interventional, non-randomized, worldwide, multi-center trial, with
      each site following a common protocol. A maximum of 1300 subjects will be implanted at a
      maximum of 40 sites in the US, Europe and Canada. The trial will include male and female
      patients of legal age to provide informed consent in the country where they enroll in the
      trial, requiring replacement for a diseased, damaged, or malfunctioning native or prosthetic
      aortic valve. Patients will be followed and assessed after implant for up to 5 years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the safety of the Model 400 valve with regard to valve-related adverse events and death.</measure>
    <time_frame>Patients are followed through 5yrs</time_frame>
    <description>Safety of the valve will be evaluated by the time-related incidence of valve-related adverse events and death. The following valve-related adverse events will be evaluated in this study: Thromboembolism, Thrombosis, Hemorrhage, Paravalvular leak (PVL), Endocarditis, Hemolysis, Structural valve deterioration, Non-structural dysfunction, Reintervention, Explant, and Death.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Confirm the effectiveness of the Model 400 valve, with regard to NYHA Functional Classification and hemodynamic performance.</measure>
    <time_frame>Patients are followed through 5yrs</time_frame>
    <description>The effectiveness endpoints are:
New York Heart Association Functional Classification (at discharge (or 30 days), 3-6 months, 1 year and annually thereafter through 5 years) as compared to Baseline.
Clinically acceptable Hemodynamic Performance (at discharge (or 30 days), 3-6 months, 1 year and annually thereafter through 5 years) confirmed by core lab evaluation of echocardiography.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1300</enrollment>
  <condition>Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>Model 400 aortic valve bioprosthesis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Model 400 aortic valve bioprosthesis</intervention_name>
    <arm_group_label>Model 400 aortic valve bioprosthesis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient has moderate or greater aortic stenosis or regurgitation, and there is
             clinical indication for replacement of their native or prosthetic aortic valve with a
             bioprosthesis, with or without concomitant procedures, which are limited to any of
             the following:

             i. LAA ligation ii. CABG iii. PFO closure iv. Ascending aortic aneurysm or dissection
             repair not requiring circulatory arrest v. Resection of a sub-aortic membrane not
             requiring myectomy

          2. Patient is geographically stable and willing to return to the implanting site for all
             follow-up visits

          3. Patient is of legal age to provide informed consent in the country where they enroll
             in the trial

          4. Patient has been adequately informed of risks and requirements of the trial and is
             willing and able to provide informed consent for participation in the clinical trial

        Exclusion Criteria:

          1. Patient has a pre-existing prosthetic valve or annuloplasty device in another
             position or requires replacement or repair of the mitral, pulmonary or tricuspid
             valve

          2. Patient has had previous implant and then explant of the Model 400 aortic valve
             bioprosthesis

          3. Patient presents with active endocarditis, active myocarditis or other systemic
             infection

          4. Patient has an anatomical abnormality which would increase surgical risk of morbidity
             or mortality, including:

               -  Ascending aortic aneurysm or dissection repair requiring circulatory arrest

               -  Acute Type A aortic dissection

               -  Ventricular aneurysm

               -  Porcelain aorta

               -  Hostile mediastinum

               -  Hypertrophic obstructive cardiomyopathy (HOCM)

               -  Documented pulmonary hypertension (systolic &gt;60mmHg)

          5. Patient has a non-cardiac major or progressive disease, with a life expectancy of
             less than 2 years. These conditions include, but are not limited to:

               -  Child-Pugh Class C liver disease

               -  Terminal cancer

               -  End-stage lung disease

          6. Patient has renal failure, defined as dialysis therapy or GFR&lt;30 mL/min/1.73 m2

          7. Patient has hyperparathyroidism

          8. Patient is participating in another investigational device or drug trial or
             observational competitive study

          9. Patient is pregnant, lactating or planning to become pregnant during the trial period

         10. Patient has a documented history of substance (drug or alcohol) abuse

         11. Patient has greater than mild mitral valve regurgitation or greater than mild
             tricuspid valve regurgitation as assessed by echocardiography

         12. Patient has systolic EF&lt;20% as assessed by echocardiography

         13. Patient has Grade IV Diastolic Dysfunction

         14. Patient has documented bleeding diatheses

         15. Patient has had an acute preoperative neurological deficit or myocardial infarction
             and has not returned to baseline or stabilized ≥30 days prior to enrollment

         16. Patient requires emergency surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Sabik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Cleveland Medical Center (Not a recuiting site)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Johannes Menno Klautz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Leiden University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aimee Weber</last_name>
    <phone>(763) 514 9757</phone>
    <email>aimee.weber@medtronic.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Southern California (USC) University Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033-5313</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Stanford Hospitals and Clinics</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kokil Bakshi</last_name>
      <phone>650-498-1232</phone>
      <email>kbakshi@stanford.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tiffany Jeanne Flores</last_name>
      <email>tflores2@stanford.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Fischbein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045-2545</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracey MacDermott</last_name>
      <phone>303-724-2757</phone>
      <email>Tracey.macdermott@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>David Fullerton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida Shands</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brittany Sumner</last_name>
      <phone>352-273-5510</phone>
      <email>brittany.sumner@surgery.ufl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jessica Cobb</last_name>
      <email>Jessica.Cobb@surgery.ufl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Thomas Beaver, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nita Cadic</last_name>
      <phone>404-605-2327</phone>
      <email>nita.cadic@piedmont.org</email>
    </contact>
    <contact_backup>
      <last_name>Shelley Holt</last_name>
      <phone>404-605-5003</phone>
      <email>Shelley.Holt@piedmont.org</email>
    </contact_backup>
    <investigator>
      <last_name>Morris Brown, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Johns</last_name>
      <phone>410-328-2737</phone>
      <email>JJohns@som.umaryland.edu</email>
    </contact>
    <contact_backup>
      <last_name>Zahid Noor</last_name>
      <phone>(410) 328-4914</phone>
      <email>zanoor@som.umaryland.edu</email>
    </contact_backup>
    <investigator>
      <last_name>James Gammie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Michigan Cardiovascular Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109-5853</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nickole Garvey, RN, BSN, CCRP</last_name>
      <phone>(734) 232-6737</phone>
      <email>ngarvey@med.umich.edu</email>
    </contact>
    <contact_backup>
      <last_name>Amanda Kasperek, RN, BSN</last_name>
      <phone>(734) 936-9664</phone>
      <email>kasperea@umich.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Himanshu Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Minneapolis Heart Institute Foundation</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407-1139</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kate Jappe</last_name>
      <phone>612-863-7347</phone>
      <email>kate.jappe@allina.com</email>
    </contact>
    <investigator>
      <last_name>Vibhu Kshettry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maimonides Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Budzilowicz, RNC, MA</last_name>
      <phone>718-283-7709</phone>
      <email>LBudzilowicz@maimonidesmed.org</email>
    </contact>
    <contact_backup>
      <last_name>Gwenn Tan-Augenstein, R.N. , M.S.</last_name>
      <phone>(718) 283-7064</phone>
      <email>GTan-Augenstein@maimonidesmed.org</email>
    </contact_backup>
    <investigator>
      <last_name>Gregory Ribakove, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Fusilero, MD</last_name>
      <phone>212-241-0029</phone>
      <email>michael.fusilero@mountsinai.org</email>
    </contact>
    <contact_backup>
      <last_name>Jerome Tonog</last_name>
      <phone>212-241-4424</phone>
      <email>jeromeandrew.tonog@mountsinai.org</email>
    </contact_backup>
    <investigator>
      <last_name>David Adams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York-Presbyterian Hospital/Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Fernandez</last_name>
      <phone>212-305-3009</phone>
      <email>sjf2132@cumc.columbia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Christopher Depender</last_name>
      <phone>(212) 305-3009</phone>
      <email>cd2686@cumc.columbia.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Borger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195-0001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Riverside Methodist Hospital (OhioHealth)</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kitra Hunter</last_name>
      <phone>614-566-1262</phone>
      <email>Kitra.Hunter@ohiohealth.com</email>
    </contact>
    <investigator>
      <last_name>Steven Duff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ProMedica Toledo Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lani Brighton, RN, CCRC</last_name>
      <phone>419-291-2373</phone>
      <email>Lani.Brighton@ProMedica.org</email>
    </contact>
    <contact_backup>
      <last_name>Vickie Shuler</last_name>
      <phone>419-291-3649</phone>
      <email>Vickie.Schuler@ProMedica.org</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Moront, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oklahoma Heart Hospital</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73135</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Heart Hospital of Austin</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756-4080</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bonnie Punske</last_name>
      <phone>512-421-3841</phone>
      <email>bonnie.punske@hcahealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Faraz Kerendi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amber Jacobs</last_name>
      <phone>713-441-3905</phone>
      <email>ajacobs@houstonmethodist.org</email>
    </contact>
    <contact_backup>
      <last_name>LaShawna Green, RN</last_name>
      <phone>(713) 441-6548</phone>
      <email>lagreen2@houstonmethodist.org</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Reardon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195-0001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miriam Silva</last_name>
      <phone>206-221-7833</phone>
      <email>silvacm8@uw.edu</email>
    </contact>
    <investigator>
      <last_name>Gabriel Aldea, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aurora Saint Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215-4330</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Cooper</last_name>
      <phone>414-385-2504</phone>
      <email>jennifer.cooper@aurora.org</email>
    </contact>
    <investigator>
      <last_name>David Kress, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre - University Campus</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Fox</last_name>
      <phone>(519) 685-8500</phone>
      <phone_ext>35031</phone_ext>
      <email>Stephanie.Fox@lhsc.on.ca</email>
    </contact>
    <investigator>
      <last_name>Michael Chu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Ottawa Heart Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 1C8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Michèle Pires</last_name>
      <phone>514-376-3330</phone>
      <phone_ext>3725</phone_ext>
      <email>Marie-michele.pires@icm-mhi.org</email>
    </contact>
    <contact_backup>
      <last_name>Steeve Grenier</last_name>
      <phone>514-376-3330</phone>
      <phone_ext>3725</phone_ext>
    </contact_backup>
    <investigator>
      <last_name>Raymond Cartier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ)</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hugo Tremblay</last_name>
      <phone>(418) 656-8711</phone>
      <phone_ext>2765</phone_ext>
      <email>hugo.tremblay@criucpq.ulaval.ca</email>
    </contact>
    <investigator>
      <last_name>Francois Dagenais, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nishit Fumakia</last_name>
      <email>Nishit.Fumakia@uhn.ca</email>
    </contact>
    <investigator>
      <last_name>Vivek Rao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Cardiologique du Haut-Lévêque</name>
      <address>
        <city>Bordeaux</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cecile JORE</last_name>
      <phone>00 335 57 65 66 66</phone>
      <email>cecile.jore@chu-bordeaux.fr</email>
    </contact>
    <contact_backup>
      <last_name>Céline Carpentier</last_name>
      <phone>05 57 65 61 68</phone>
      <email>celine.carpentier@chu-bordeaux.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Prof. Louis Labrousse, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Bichat - Claude Bernard</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bensari Nawel, MD</last_name>
      <phone>0033 140257468</phone>
      <email>nawel.bensari@bch.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Bensari Nawel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Köln - Anstalt des öffentlichen Rechts</name>
      <address>
        <city>Cologne</city>
        <state>Köln</state>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum München</name>
      <address>
        <city>Munich</city>
        <state>München</state>
        <zip>o 80636</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum und Fachbereich Medizin Johann Wolfgang Goethe-Universität Frankfurt am Main</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Leipzig GmbH</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale San Raffaele - Milano</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Leids Universitair Medisch Centrum (LUMC)</name>
      <address>
        <city>Leiden</city>
        <zip>2333 ZA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mrs. Eline Bruggemans</last_name>
      <phone>+31 71 526 4581</phone>
      <email>E.F.Bruggemans@lumc.nl</email>
    </contact>
    <investigator>
      <last_name>Prof. Robert Klautz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erasmus MC</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015 CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mrs. Liesbeth W. Duininck</last_name>
      <phone>+31 107032150</phone>
      <email>research.thoraxchirurgie@erasmusmc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Mrs. Usha Jadoenath</last_name>
      <phone>+31 107032150</phone>
      <email>research.thoraxchirurgie@erasmusmc.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Prof. A. Pieter Kappetein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inselspital - Universitätsspital Bern</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UniversitätsSpital Zürich</name>
      <address>
        <city>Zürich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Guy's &amp; St Thomas' NHS Foundation Trust - St Thomas' Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Smith</last_name>
      <phone>+44 20/71.88.71.88</phone>
      <phone_ext>54209</phone_ext>
      <email>megan.smith@gstt.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Mr. Vinayak Bapat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 20, 2017</lastchanged_date>
  <firstreceived_date>March 4, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
